Location History:
- Santa Ana, CA (US) (1990 - 1991)
- Newport Beach, CA (US) (1992)
- Balboa Station, Newport Beach, CA (US) (1995)
- Boynton Beach, FL (US) (2003)
- Seneca, MO (US) (2000 - 2004)
- Kansas City, KS (US) (2013 - 2020)
Company Filing History:
4 out of 6 
3 out of 22 
2 out of 171 
Years Active: 1990-2020
Title: Gregory B Mills: Innovator in Olfactory Dysfunction Detection
Introduction
Gregory B Mills is a notable inventor based in Kansas City, KS (US), recognized for his contributions to the field of medical diagnostics. With a total of 16 patents to his name, Mills has focused on developing innovative devices and methods aimed at detecting degenerative disorders of the central nervous system, particularly those related to olfactory dysfunction.
Latest Patents
Mills' latest patents include groundbreaking systems and methods for testing for degenerative disorders of the central nervous system. One of his significant inventions involves devices and methods for detecting and evaluating olfactory dysfunction by measuring the olfactory detection threshold for both the left and right nostrils. This invention is particularly relevant for diagnosing and monitoring olfactory deterioration associated with Alzheimer's disease. Another notable patent focuses on screening patients for Alzheimer's disease through the assessment of olfactory detection thresholds, utilizing cascading aromas to enhance the detection process.
Career Highlights
Throughout his career, Gregory B Mills has made substantial advancements in the medical technology sector. His work has been instrumental in developing tools that aid in the early detection of neurodegenerative diseases, thereby improving patient outcomes. Mills' innovative approach combines scientific research with practical applications, making significant strides in the field of olfactory dysfunction.
Collaborations
Mills has collaborated with various professionals in his field, including George Pelling, to further enhance the development of his inventions. These collaborations have allowed for a more comprehensive approach to tackling the challenges associated with olfactory dysfunction and its implications for neurodegenerative diseases.
Conclusion
Gregory B Mills stands out as a pioneering inventor whose work in olfactory dysfunction detection has the potential to transform the landscape of medical diagnostics. His innovative patents and collaborative efforts continue to contribute to advancements in understanding and treating degenerative disorders.